Pharmaceutical News

RSS
Abraxane, first in a new class of albumin-bound nanotechnology for the treatment of metastatic breast cancer

Abraxane, first in a new class of albumin-bound nanotechnology for the treatment of metastatic breast cancer

FDA approves Abraxane for metastatic breast cancer

FDA approves Abraxane for metastatic breast cancer

Fallout from Vioxx and Celebrex market recall challenges industry

Fallout from Vioxx and Celebrex market recall challenges industry

FDA clearance to test influenza vaccine, Fluviral

FDA clearance to test influenza vaccine, Fluviral

States to explore putting restrictions on AIDS drug Trizivir

States to explore putting restrictions on AIDS drug Trizivir

European approval of Cymbalta/Xeristar for treatment of major depressive episodes

European approval of Cymbalta/Xeristar for treatment of major depressive episodes

Bush Administration pressures Canada to eliminate drug importation

Bush Administration pressures Canada to eliminate drug importation

First new leukemia treatment approved specifically for children in more than a decade

First new leukemia treatment approved specifically for children in more than a decade

The rise in over the counter drugs, why?

The rise in over the counter drugs, why?

Eli Lilly aware in the 1980s that fluoxetine had troubling side effects

Eli Lilly aware in the 1980s that fluoxetine had troubling side effects

New painkiller was discovered in natural form in venomous snails in 1979

New painkiller was discovered in natural form in venomous snails in 1979

Information submitted via new drug applications could easily be made accessible to the public

Information submitted via new drug applications could easily be made accessible to the public

Lessons learned from troubles with COX-2 inhibitors

Lessons learned from troubles with COX-2 inhibitors

Update on world antimalarial drug supply

Update on world antimalarial drug supply

Supply problem with the opiate painkiller, diamorphine

Supply problem with the opiate painkiller, diamorphine

FDA issues not approvable letter to Cellegy Pharmaceuticals

FDA issues not approvable letter to Cellegy Pharmaceuticals

Public health advisory for the use of non-steroidal anti-inflammatory drug products

Public health advisory for the use of non-steroidal anti-inflammatory drug products

FDA approves Enablex for the treatment of overactive bladder

FDA approves Enablex for the treatment of overactive bladder

Pharmacogenomics, has the potential to spark a major, technology-driven restructuring of the health care and pharmaceuticals industries

Pharmacogenomics, has the potential to spark a major, technology-driven restructuring of the health care and pharmaceuticals industries

Arthritis drug caution advised by New Zealand experts

Arthritis drug caution advised by New Zealand experts

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.